Lv6
1810 积分 2023-07-20 加入
RNA structure guides antiviral ASO design
1个月前
已完结
Advancing ASO therapies from development to implementation
1个月前
已完结
Antibody framework residues affecting the conformation of the hypervariable loops
1个月前
已完结
Antibody modeling: Beyond homology
1个月前
已完结
Patisiran, an investigational RNAi therapeutic for patients with hereditary transthyretin-mediated (hATTR) amyloidosis : Results from the phase 3 APOLLO study
1个月前
已完结
Antibody modeling: Beyond homology
1个月前
已完结
Enhanced Delivery of Ligand-Conjugated Antisense Oligonucleotides (C16-HA-ASO) Targeting Dystrophia Myotonica Protein Kinase Transcripts for the Treatment of Myotonic Dystrophy Type 1
2个月前
已完结
SGN-CD19B, a Pyrrolobenzodiazepine (PBD)-Based Anti-CD19 Drug Conjugate, Demonstrates Potent Preclinical Activity Against B-Cell Malignancies
2个月前
已完结
SGN-CD19B, a Pyrrolobenzodiazepine (PBD)-Based Anti-CD19 Drug Conjugate, Demonstrates Potent Preclinical Activity Against B-Cell Malignancies
2个月前
已关闭
MEDI-551, a Humanized Monoclonal Anti-CD19, in Adults with Relapsed or Refractory Advanced B-Cell Malignancies: Results From a Phase 1/2 Study
2个月前
已完结
皖公网安备34019202002308
